statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	866
SG - Singapore	198
CN - Cina	107
GB - Regno Unito	77
FI - Finlandia	66
HK - Hong Kong	65
SE - Svezia	64
BR - Brasile	62
DE - Germania	56
VN - Vietnam	55
IT - Italia	44
RU - Federazione Russa	29
FR - Francia	27
CA - Canada	16
IN - India	12
KR - Corea	11
MX - Messico	11
ID - Indonesia	9
PL - Polonia	8
JP - Giappone	7
ZA - Sudafrica	7
AR - Argentina	6
BG - Bulgaria	6
MA - Marocco	6
SI - Slovenia	6
TR - Turchia	6
AT - Austria	5
IQ - Iraq	5
MY - Malesia	5
NL - Olanda	5
PK - Pakistan	5
UZ - Uzbekistan	5
BD - Bangladesh	4
UA - Ucraina	4
VE - Venezuela	4
CO - Colombia	3
LT - Lituania	3
PH - Filippine	3
AE - Emirati Arabi Uniti	2
BE - Belgio	2
CL - Cile	2
DZ - Algeria	2
ES - Italia	2
IR - Iran	2
KE - Kenya	2
NI - Nicaragua	2
NP - Nepal	2
NZ - Nuova Zelanda	2
PA - Panama	2
PY - Paraguay	2
RS - Serbia	2
AD - Andorra	1
AG - Antigua e Barbuda	1
BF - Burkina Faso	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
ET - Etiopia	1
IE - Irlanda	1
JM - Giamaica	1
JO - Giordania	1
LA - Repubblica Popolare Democratica del Laos	1
PE - Perù	1
PT - Portogallo	1
QA - Qatar	1
RO - Romania	1
SA - Arabia Saudita	1
TN - Tunisia	1
TW - Taiwan	1
ZM - Zambia	1
Totale	1.924

Nome	#
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study	292
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison	275
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART	259
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients	203
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort	197
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study	195
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy	185
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART	165
Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe	163
Totale	1.934

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	26	0	0	0	0	0	0	0	0	0	6	16	4
2021/2022	109	1	9	8	2	5	2	3	7	18	4	24	26
2022/2023	241	38	34	23	15	34	17	7	26	14	0	11	22
2023/2024	128	4	10	12	15	29	10	13	17	1	3	5	9
2024/2025	467	14	7	4	42	75	69	44	22	63	18	36	73
2025/2026	758	63	36	46	98	155	68	124	34	67	67	0	0
Totale													1.934